Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Shock as Orbán allies take ownership of Hungary’s most-read newspaper
5/11/2025
I miss the days before people like me were looked on with suspicion in the streets of Amsterdam | Jamal Mahjoub
5/11/2025
‘The sheer ineptitude has been staggering’ : what we learned from The Celebrity Traitors
5/11/2025
‘I thought ‘Bond girl’ was such a demeaning term’ : Famke Janssen on acting, ambition and Woody Allen
5/11/2025
‘A historic victory’ : our panel reacts to Zohran Mamdani’s triumph | Panel
5/11/2025
At least seven dead and 11 injured after UPS plane crashes near a Kentucky airport
5/11/2025